CoChat

Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis

Open access
Li, S., Villarreal, M., Stewart, S., Choi, J., Ganguli-Indra, G., Babineau, D.C., Philpot, C., David, G., Yoshida, T., Boguniewicz, M., Hanifin, J.M., Beck, L.A., Leung, D.Y., Simpson, E.L., Indra, A.K. · 2017 · British Journal of Dermatology
Cited by 82

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Dear Editor, Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by disrupted epidermal barrier functions.1 The stratum corneum (SC) consists of corneocytes and a lipid‐rich extracellular matrix, which plays a key role in epidermal permeability barrier functions.2,3 Major lipid constituents of the SC are ceramides, free fatty acids (FFAs), cholesterol and triglycerides.2,3,Staphylococcus aureus colonization is an important trigger of AD.4 Comprehensive profiling of SC lipids using S. aureus colonization status, and association between S. aureus colonization and skin lipid composition have never been documented. In our study cohort, 27 patients with AD and 15 healthy individuals with no history of skin disorders (age ≥ 18 years) were enrolled under an institutional review board‐approved protocol. All participants with AD had elevated transepidermal water loss (TEWL), thymus and activation‐regulated chemokine (TARC)/CCL17, total serum IgE levels and eosinophil counts (clinical markers of AD severity)5 compared with nonatopic participants before and after adjustment for age and sex (Fig. 1). We extracted SC lipids using a high‐yield, one‐step, modified Bligh and Dyer method,6 and all major SC lipids were analysed by liquid chromatography–tandem mass spectroscopy. Hypothetical model of altered lipid distribution in skin of participants with atopic dermatitis (AD) with or without Staphylococcus aureus colonization (S. aureus− and S. aureus+, respectively). Basal transepidermal water loss (TEWL), serum IgE, serum thymus and activation‐regulated chemokine (TARC/CCL17) and eosinophils are significantly elevated in S. aureus− and S. aureus+ patients with AD compared with nonatopic participants (green arrows). The levels of ceramides CER[AH]C48, CER[EOH]C66, CER[EOH]C68 and CER[EOS]C70; free fatty acids FFA16:1 and FFA18:1; and triglycerides TG46:2, TG48:2, TG50:2 and TG50:3 are significantly downregulated in S. aureus+ patients with AD compared with S. aureus− patients (red arrows). The level of cholesterol‐3‐sulfate is significantly increased in patients with AD both with and without S. aureus colonization compared with nonatopic individuals (green arrows). Ceramides are the most abundant lipid class in human SC (50%) and are divided into 12 subclasses.3 Consequently, the profile of SC lipids was compared between patients with AD with S. aureus colonization (S. aureus+, n =15), patients with AD without S. aureus colonization (S. aureus−, n =12) and nonatopic participants without S. aureus (n =15). Certain short‐chain ceramides, such as CER[AH]C34 and CER[AP]C34 (both 34 carbons in length), were significantly more abundant in patients with AD than in nonatopic participants, as reported previously.3 Specific ceramides, belonging to four of the 12 subclasses, differed between patients with AD with and without S. aureus. The levels of CER[AH] (44, 48, 50 and 52 carbons), CER[AP] (40 carbons) and very‐long‐chain ceramides – including CER[EOH] (66, 68 and 70 carbons) and CER[EOS] (70 carbons) – were significantly lower in S. aureus+ patients with AD than S. aureus− patients (Fig. 1). After age and sex adjustment, levels of CER[AH]C38, CER[AH]C48, CER[AP]C40, CER[EOH]C66, CER[EOH]C68 and CER[EOS]C70 were significantly lower in S. aureus+ patients with AD (Table S1; see Supporting Information). Basal TEWL negatively correlated with levels of certain ceramides, including CER[AH]C48, CER[AH]C50, CER[AP]C36, CER[EOH]C66, CER[EOH]C68, CER[EOS]C70, CER[NDS]C52 and CER[NDS]C54. Interestingly, CER[NDS]C52 and CER[NDS]C54 were significantly lower in S. aureus+ patients with AD than in nonatopic participants, but were comparable between S. aureus+ and S. aureus− participants with AD, suggesting that this subgroup of lipids might be involved only in epidermal permeability barrier homeostasis. However, CER[AH]C38 and CER[AP]C40 were significantly lower only in S. aureus+ patients with AD than in S. aureus− patients with AD, and no correlation with TEWL values was observed. This suggests that those ceramides might exhibit only antimicrobial activities or provide a survival advantage for S. aureus. The levels of very‐long‐chain ceramides – such as CER[EOH]C66, CER[EOH]C68 and CER[EOS]C70 – were significantly decreased in S. aureus+ patients with AD compared with S. aureus− patients, and negatively correlated with TEWL (Table S1). Cholesterol and cholesterol‐3‐sulfate are abundant in human epidermis. Here, the level of cholesterol was comparable among all groups as reported previously.7 Interestingly, compared with nonatopic participants, patients with AD showed significantly increased cholesterol‐3‐sulfate, irrespective of S. aureus colonization, age and sex (Fig. 1, Table S1). Increased cholesterol‐3‐sulfate was also associated with increased basal TEWL (Table S1), suggesting that increased cholesterol‐3‐sulfate level may be a risk factor for AD in general, and a possible contributor to barrier disruptions. A r

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjd.15409

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Li, S., Villarreal, M., Stewart, S., Choi, J., Ganguli-Indra, G., Babineau, D. C., Philpot, C., David, G., Yoshida, T., Boguniewicz, M., Hanifin, J. M., Beck, L. A., Leung, D. Y., Simpson, E. L., & Indra, A. K.
Venue
British Journal of Dermatology
Published
2017-09-05
Volume
177
Issue
4
Pages
e125-e127
ISSN
0007-0963 (ISSN-L)
OpenAlex
W2592440684
Cited by
82
References
3
FWCI
8.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.